Charlie McDermott was Appointed as Chairman, President and Chief Executive Officer at Primmune-Therapeutics

Date of management change: March 15, 2019 

What Happened?

San Diego, CA-based Primmune-Therapeutics Appointed Charlie McDermott as Chairman, President and Chief Executive Officer

 

About the Company

Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to current and future immunotherapy medicines.

 

About the Person

Charlie McDermott is Chairman, President and Chief Executive Officer at Primmune Therapeutics. Previously, Charlie held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: McGilvray Adam, Ganesan Anitha, Houck Schyler, Mortellaro Kayla, Boland Linda, Park Julian, Browne Janelle, Curtiss Elaine, Sullivan Lisa, Badiozamani Ghazal, Spence Jeff

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.